Previous close | 159.64 |
Open | 160.84 |
Bid | 0.00 x 800 |
Ask | 0.00 x 900 |
Day's range | 159.60 - 162.48 |
52-week range | 132.24 - 243.52 |
Volume | |
Avg. volume | 1,578,191 |
Market cap | 23.76B |
Beta (5Y monthly) | 0.55 |
PE ratio (TTM) | 26.27 |
EPS (TTM) | 6.15 |
Earnings date | 24 Jan 2024 - 29 Jan 2024 |
Forward dividend & yield | 1.92 (1.19%) |
Ex-dividend date | 08 Nov 2023 |
1y target est | 178.38 |
Envista (NVST) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
ResMed Inc (NYSE:RMD), a global leader in the development, manufacturing, and marketing of innovative medical products for the treatment and management of respiratory disorders, with a focus on sleep-disordered breathing, has recently witnessed a significant insider sell by its Chief Financial Officer (CFO), Brett Sandercock.